114223-13-1

Basic information

• Product Name: 3-(3-methylphenoxy)-3-oxopropanoic acid
• Synonyms: 3-(3-methylphenoxy)-3-oxopropanoic acid
• CAS NO: 114223-13-1
• Molecular Weight: 194.187
• Mol File: 114223-13-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-(3-methylphenoxy)-3-oxopropanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(3-methylphenoxy)-3-oxopropanoic acid(114223-13-1)
• EPA Substance Registry System: 3-(3-methylphenoxy)-3-oxopropanoic acid(114223-13-1)

Safety Data

• Hazardous Substances Data: 114223-13-1(Hazardous Substances Data)

Upstream product

• 2033-24-1 cycl-isopropylidene malonate 
• 108-39-4 3-methyl-phenol 
• 141-82-2 malonic acid 

Downstream Products

• 18692-77-8 4-hydroxy-7-methyl-2H-chromen-2-one 
• 567-61-3 2-hydroxy-6-methylbenzoic acid 
• 50-85-1 2-hydroxy-p-toluic acid 

Relevant articles and documents

Synthesis and evaluation of antibacterial and anti-inflammatory properties of naturally occurring coumarins

Coumarins are a group of heterocyclic compounds naturally present in a large variety of plant families. Nevertheless, oxyprenylated coumarins have been only recently seen as valuable and promising biologically active phytochemicals. In this study, we synthesized three naturally occurring O-prenylcoumarins (1), (2), and (3), and evaluated their antibacterial and anti-inflammatory properties in view of their therapeutic potential against periodontal disease. The three O-prenylcoumarins were synthesized using well-known schemes leading to the chromen-2-one nucleus. The periodontal pathogen Porphyromonas gingivalis was found to be highly susceptible to all three O-prenylcoumarins with minimal inhibitory concentration values in the range of 12.5-25 mg/ml; the non-prenylated forms of the coumarins did not show any activity. The antibacterial activity of (1), (2), and (3) appeared to result from its ability to permeate the cell membrane. Using the U937-3xkB-LUC human monocytic cell line, compounds (2) and (3) dose-dependently inhibited lipopolysaccharide-induced NF-kB activation, while (1) did not. The non-prenylated forms of the coumarins were either inactive or much less potent. In conclusion, O-prenylcoumarins (2) and (3) by exhibiting a dual mode of action including antibacterial and anti-inflammatory activities may represent promising targeted therapeutic agents for localized treatment of periodontal diseases.